1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Results 81-100 of 150 (Search time: 0.013 seconds).

Publication YearTitleAuthor(s)
8130-Jul-2014Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma.Jayachandran, Aparna; Anaka, Matthew; Prithviraj, Prashanth; Hudson, Christopher; McKeown, Sonja J; Lo, Pu-Han; Vella, Laura J; Goding, Colin R; Cebon, Jonathan S ; Behren, Andreas
8218-Jul-2014Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.Robson, Neil C; Hidalgo, Laura; McAlpine, Tristan; Wei, Heng; Martínez, Víctor G; Entrena, Ana; Melen, Gustavo J; MacDonald, Andrew S; Phythian-Adams, Alexander; Sacedón, Rosa; Maraskovsky, Eugene; Cebon, Jonathan S ; Ramírez, Manuel; Vicente, Angeles; Varas, Alberto
833-Jul-2014The kinase inhibitors dabrafenib and trametinib affect isolated immune cell populations.Vella, Laura J; Andrews, Miles C; Pasam, Anupama; Woods, Katherine; Behren, Andreas; Cebon, Jonathan S 
8417-Jun-2014Immune consequences of kinase inhibitors in development, undergoing clinical trials and in current use in melanoma treatment.Vella, Laura J; Andrews, Miles C; Behren, Andreas; Cebon, Jonathan S ; Woods, Katherine
851-Jun-2014Evolving role of tumor antigens for future melanoma therapies.Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas
8614-Apr-2014Mapping the distinctive populations of lymphatic endothelial cells in different zones of human lymph nodes.Park, Saem Mul; Angel, Catherine E; McIntosh, Julie D; Mansell, Claudia J; Chen, Chun-Jen J; Cebon, Jonathan S ; Dunbar, P Rod
871-Apr-2014A single-centre experience of patients with metastatic melanoma enrolled in a dabrafenib named patient programme.Lau, David K ; Andrews, Miles C; Turner, Natalie; Azad, Arun A; Davis, Ian D; Cebon, Jonathan S 
8815-Jan-2014FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.Tan, BeeShin; Anaka, Matthew; Deb, Siddhartha; Freyer, Claudia; Ebert, Lisa M; Chueh, Anderly C; Al-Obaidi, Sheren; Behren, Andreas; Jayachandran, Aparna; Cebon, Jonathan S ; Chen, Weisan; Mariadason, John M 
894-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
9011-Oct-2013Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.Anaka, Matthew; Hudson, Christopher; Lo, Pu-Han; Do, Hongdo; Caballero, Otavia L; Davis, Ian D; Dobrovic, Alexander ; Cebon, Jonathan S ; Behren, Andreas
1123-Jul-2013The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S 
1217-Jul-2013Tumor-specific T-cell help is associated with improved survival in melanoma.Woods, Katherine; Cebon, Jonathan S 
1311-Apr-2013The Ludwig institute for cancer research Melbourne melanoma cell line panel.Behren, Andreas; Anaka, Matthew; Lo, Pu-Han; Vella, Laura J; Davis, Ian D; Catimel, Jenny; Cardwell, Tracy; Gedye, Craig; Hudson, Christopher; Stan, Rodica; Cebon, Jonathan S 
1427-Feb-2013Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein.Komatsu, Nobukazu; Jackson, Heather M; Chan, Kok-fei; Oveissi, Sara; Cebon, Jonathan S ; Itoh, Kyogo; Chen, Weisan
1526-Oct-2012A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.Ebert, Lisa M; MacRaild, Sarah E; Zanker, Damien; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
166-Sep-2012A novel HLA-B18 restricted CD8+ T cell epitope is efficiently cross-presented by dendritic cells from soluble tumor antigen.Zhao, Rona Y; Mifsud, Nicole A; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J; Lowen, Tamara; Robson, Neil C; Russell, Sarah E; Scotet, Emmanuel; Davis, Ian D; Maraskovsky, Eugene; Cebon, Jonathan S ; Luescher, Immanuel F; Chen, Weisan
1726-Aug-2012Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy.Knights, Ashley J; Fucikova, Jitka; Pasam, Anupama; Koernig, Sandra; Cebon, Jonathan S 
181-Feb-2012Stem cell media culture of melanoma results in the induction of a nonrepresentative neural expression profile.Anaka, Matthew; Freyer, Claudia; Gedye, Craig; Caballero, Otavia; Davis, Ian D; Behren, Andreas; Cebon, Jonathan S 
1913-Jan-2012A novel method for detecting antigen-specific human regulatory T cells.Ebert, Lisa M; MacRaild, Sarah E; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
2023-Jun-2011Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™.Nicholaou, Theo; Chen, Weisan; Davis, Ian D; Jackson, Heather M; Dimopoulos, Nektaria; Barrow, Catherine; Browning, Judy; Macgregor, Duncan; Williams, David; Hopkins, Wendie; Maraskovsky, Eugene; Venhaus, Ralph; Pan, Linda; Hoffman, Eric W; Old, Lloyd J; Cebon, Jonathan S